Medtronic, a global leader in healthcare technology, today announced that four of its technologies have received Japan’s 2025 Good Design Award, a comprehensive national recognition for design excellence. This is the first year that four Medtronic technologies have received the award.

全球医疗技术领导者美敦力公司今日宣布，其四项技术荣获日本2025年优良设计奖，这是对设计卓越性的全国性综合认可。这也是美敦力首次有四项技术同时获得该奖项。

The 2025 Medtronic Good Design Award winning solutions are:

2025年美敦力优秀设计奖的获奖解决方案是：

PROPEL™ Sinus Implant

PROPEL™ 鼻窦植入物

– Japan’s first bioabsorbable, steroid-eluting sinus implant that supports postoperative healing and reduces recurrence risk following sinus surgery.

– 日本首款可生物吸收、含类固醇的鼻窦植入物，有助于术后愈合并降低鼻窦手术后的复发风险。

Aurora EV-ICD™ MRI System

极光 EV-ICD™ 核磁共振成像系统

– First-of-its-kind extravascular ICD system, designed to reduce procedural risk and improve patient comfort by eliminating the need for transvenous leads, instead positioning the Epsila™ EV MRI lead beneath the sternum.

首款腔外ICD系统，通过消除对经静脉导线的需求来降低手术风险并提高患者舒适度，而是将Epsila™ EV MRI导线置于胸骨下方。

Onyx Frontier™ Coronary Stent

Onyx Frontier™ 冠状动脉支架

– A next-generation stent delivery system that combines increased catheter flexibility and deliverability, and a lower crossing profile to treat complex coronary lesions.  Onyx Frontier offers a broad size matrix, including Japan’s smallest 2.0 mm stent for small vessels.

– 一款下一代支架输送系统，结合了更高的导管灵活性和输送性，并具有更低的穿越剖面，用于治疗复杂的冠状动脉病变。Onyx Frontier 提供广泛的尺寸矩阵，包括日本最小的2.0毫米小血管支架。

Evolut™ FX+ Transcatheter Aortic Valve Replacement (TAVR) System

Evolut™ FX+ 经导管主动脉瓣置换术（TAVR）系统

– An enhanced frame design with addition of larger windows to facilitate coronary access to leverage market-leading valve performance.

- 通过增加更大的窗口来改进框架设计，以促进冠状动脉的通路，从而利用市场领先的瓣膜性能。

Organized by the Japan Institute of Design Promotion, the annual Good Design Award recognizes a variety of products based on efficacy, utility, and potential to enrich both individual lives and society at large.

由日本设计振兴会组织的年度优良设计奖，根据产品的功效、实用性以及对个人生活和社会的潜在丰富性来表彰各类产品。

The Good Design Award jury recognized all four Medtronic technologies for their combination of technical innovation, clinical impact, and human-centered design. Each product was praised for addressing complex medical challenges through thoughtful engineering that improves quality of care and patient outcomes..

优良设计奖评审团认可了美敦力公司的四项技术，这些技术结合了技术创新、临床影响和以人为中心的设计。每个产品都因通过周到的工程设计解决了复杂的医疗挑战，提高了护理质量和患者疗效而受到赞扬。

About the Good Design Award

关于优良设计奖

Established in 1957, the Good Design Award is Japan’s leading program for the comprehensive evaluation and promotion of design, succeeding the original Good Design Selection System.  Recognized globally, the award attracts participation from numerous companies and organizations both in Japan and overseas.  Held annually, it aims to enhance the quality of life and leverage the power of design to address social challenges and emerging themes.  The symbol of the award, the “G Mark,” is widely recognized as a mark of excellence in design.

成立于1957年，优良设计奖是日本领先的综合性设计评估与推广项目，继承了最初的优良设计评选制度。该奖项在全球范围内广受认可，吸引了来自日本及海外众多公司和组织的参与。每年举办一次，旨在提升生活品质，并利用设计的力量应对社会挑战和新兴主题。奖项标志“G Mark”被广泛认为是卓越设计的象征。

Visit .

访问。

www.g-mark.org

www.g-mark.org

.

。

About Medtronic

美敦力公司简介

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries.

大胆思考。更果敢的行动。我们是美敦力。美敦力公司总部位于爱尔兰戈尔韦，是全球领先的医疗技术公司，通过寻找并发现解决方案，大胆应对人类面临的最严峻的健康问题。我们的使命——减轻病痛、恢复健康、延长生命——团结了遍布150多个国家的95,000多名充满热情的员工。

Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day.

我们的技术和疗法治疗70种健康状况，包括心脏设备、手术机器人、胰岛素泵、手术工具、患者监测系统等。凭借我们多样化的知识、无尽的好奇心和帮助所有需要帮助的人的愿望，我们提供了创新的技术，每秒、每小时、每一天都在改变两个人的生活。

Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit .

期待我们做得更多，因为我们赋予洞察力驱动的关怀，优先考虑人的体验，并为我们的世界带来更好的结果。在我们所做的一切中，我们正在创造非凡。欲了解有关美敦力的更多信息，请访问。

www.Medtronic.com

www.美敦力.com

and follow on

接着进行

LinkedIn

领英

.

。

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

任何前瞻性陈述均受风险和不确定性的影响，例如美敦力向证券交易委员会提交的定期报告中描述的风险和不确定性。实际结果可能与预期结果有重大差异。

Contacts:

联系人：

Marie Gentile

玛丽·詹蒂尔

Public Relations

公共关系

+1-404-693-6028

+1-404-693-6028

Ryan Weispfenning

瑞安·魏斯芬宁

Investor Relations

投资者关系

+1-763-505-4626

+1-763-505-4626